Simponi
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIMPONI®(191120)ACMI Golimumab (rmc) Consumer Medicine Information What
Read moreTreating critically ill COVID-19 patients with drugs typically used for arthritis may significantly improve survival, a landmark study has found.
Read moreThe American College of Rheumatology (ACR) will preview the 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis at ACR
Read moreArthritis affects almost 2% of the world’s population, or some 150 million people, and currently, there is no completely effective
Read moreArthritis is a common condition that can affect people of all ages, according to the NHS. But you could lower
Read moreArthritis and diet: More fiber It has long been known that the addition of the drug, physical and surgical therapy,
Read moreArthritis is an umbrella term for more than 100 types of joint-related conditions but the most prevalent in the UK
Read moreA drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study
Read moreArthritis is a common condition that can affect people of all ages, according to the NHS. The most common symptoms
Read moreThe arthritis drug tocilizumab has shown early promise in preventing extreme inflammation in gravely ill COVID-19 patients, according to a
Read more